Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,033 | 2,481 | 3,107 | 254 | 47 |
| Receivables | 3 | 3 | 5 | 1 | 5 |
| TOTAL | $2,279 | $2,712 | $3,442 | $507 | $347 |
| Non-Current Assets | |||||
| PPE Net | 26 | 29 | 32 | 35 | 38 |
| Other Non-Current Assets | 139 | 15 | 40 | 59 | 81 |
| TOTAL | $165 | $44 | $71 | $94 | $119 |
| Total Assets | $2,443 | $2,756 | $3,513 | $600 | $466 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 200 | 200 | 200 | 200 | N/A |
| Accounts payable and accrued liabilities | 1,894 | 1,598 | 1,288 | 1,260 | 1,209 |
| Accrued Expenses | 82 | 46 | 17 | 2 | N/A |
| Other current liabilities | N/A | N/A | 150 | 150 | N/A |
| TOTAL | $8,494 | $7,825 | $7,701 | $3,549 | $3,077 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,991 | 2,312 | 2,500 | N/A | N/A |
| Other Non-Current Liabilities | 96 | 0 | 0 | 0 | 0 |
| TOTAL | $96 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $8,591 | $7,825 | $7,701 | $3,549 | $3,077 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 419,497 | 419,447 | 419,447 | 419,447 | 404,007 |
| Common Shares | 419 | 419 | 419 | 419 | 404 |
| Retained earnings | -248,143 | -247,065 | -246,034 | -244,795 | -243,744 |
| Other shareholders' equity | -14 | -14 | -22 | -13 | -13 |
| TOTAL | $-6,147 | $-5,069 | $-4,187 | $-2,949 | $-2,611 |
| Total Liabilities And Equity | $2,443 | $2,756 | $3,513 | $600 | $466 |